Who
Amir Shojaei
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Harrow.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $900K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jan 2025
- Last trade
- 14 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 17 Aug 2026 | HROW HarrowPharmaceuticals | SEC FORM 4 Code M | $405K11,250 at $35.96 | filing |
| 14 Aug 2026filed 17 Aug 2026 | HROW HarrowPharmaceuticals | SEC FORM 4 Sold | $450K11,250 at $40.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | HROW Harrowoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $405K11,250 at $35.96 | filing |
| 14 Aug 2026filed 17 Aug 2026 | HROW Harrowoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $405K11,250 at $35.96 | filing |
| 14 Aug 2026filed 17 Aug 2026 | HROW HarrowPharmaceuticals | SEC FORM 4 Code M | $405K11,250 at $35.96 | filing |
| 14 Aug 2026filed 17 Aug 2026 | HROW HarrowPharmaceuticals | SEC FORM 4 Sold | $450K11,250 at $40.00 | filing |
| 15 May 2026filed 18 May 2026 | HROW Harrowoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | HROW Harrowoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | HROW Harrowoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
Comparing Harrow (NASDAQ:HROW) & Teva Pharmaceutical Industries (NYSE:TEVA)HROW · tickerreport.com · 16 Oct 2026
0 headlines in the last 90 days name Amir Shojaei; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.